IL-6 derived from MSCs, along with other bioactive factors secreted by them, promises to enhance the therapeutic efficacy of MSC-based treatments in neurological disorders, contributing to neuroprotection, neuroregeneration, and immunomodulation in the CNS. Here, IL6 is linked to nervous system disorder.